Hobyung Chung Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2022	Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
12/2015	Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil.
9/2012	Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
4/2012	Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma.
5/2011	[Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma].
2/2011	The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
1/2011	Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.
1/2011	Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
1/2011	Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
7/2010	Single HCC between 2 and 5 cm: the grey zone: hepatologist's perspective.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hobyung Chung Research Topics

Disease

47	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2002
25	Neoplasms (Cancer) 09/2012 - 01/2003
6	Fibrosis (Cirrhosis) 01/2011 - 12/2005
5	Neoplasm Metastasis (Metastasis) 05/2010 - 12/2002
4	Infections 02/2024 - 12/2006
4	Chronic Hepatitis C 01/2011 - 12/2006
3	Autoimmune Hepatitis 02/2024 - 02/2010
3	Hepatitis C 01/2017 - 12/2006
3	Hepatitis 02/2010 - 01/2003
3	Chronic Hepatitis (Chronic Active Hepatitis) 02/2010 - 12/2005
2	Sclerosing Cholangitis 02/2024 - 02/2010
2	Autoimmune Pancreatitis 01/2013 - 02/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011 - 12/2006
2	Iron Overload 01/2008 - 12/2006
2	Liver Diseases (Liver Disease) 12/2005 - 01/2003
2	Liver Neoplasms (Liver Cancer) 12/2004 - 01/2003
2	Pleural Effusion (Pleural Effusions) 05/2004 - 01/2003
2	Hemangioma (Angioma) 04/2004 - 12/2002
2	Thrombosis (Thrombus) 01/2003 - 01/2003
1	Viremia 02/2024
1	Proteinuria 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 05/2019
1	Angiomyolipoma 01/2017
1	Gastrinoma 07/2015
1	Immunoglobulin G4-Related Disease 01/2013
1	Pancreatic Diseases (Pancreatic Disease) 01/2013
1	Hypoxia (Hypoxemia) 01/2011
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2010
1	Sclerosis 12/2009
1	Polycystic liver disease 12/2009
1	Cysts 12/2009
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 03/2008
1	Residual Neoplasm 01/2008
1	Jaundice (Icterus) 01/2008
1	Hyperferritinemia 12/2006
1	Ascites 02/2006
1	Focal Nodular Hyperplasia 04/2004

Drug/Important Bio-Agent (IBA)

11	InterferonsIBA 01/2018 - 01/2003
7	SonazoidIBA 01/2017 - 01/2008
6	SHU 508 (Levovist)IBA 07/2010 - 03/2003
6	Coloring Agents (Dyes)IBA 04/2004 - 12/2002
5	Contrast MediaIBA 01/2008 - 06/2003
4	Immunoglobulin G (IgG)IBA 02/2024 - 02/2010
4	acarboxyprothrombin (PIVKA)IBA 08/2008 - 12/2006
2	EnzymesIBA 02/2024 - 01/2013
2	Antiviral Agents (Antivirals)IBA 02/2024 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 12/2015 - 07/2010
2	Sorafenib (BAY 43-9006)FDA Link 12/2015 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 07/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 02/2010
2	AutoantibodiesIBA 01/2013 - 02/2010
2	GadoliniumIBA 09/2012 - 01/2011
2	gadolinium ethoxybenzyl DTPA FDA Link 09/2012 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 01/2008
2	Ribavirin (Virazole)FDA LinkGeneric 01/2011 - 01/2010
2	Ferritins (Ferritin)IBA 01/2010 - 12/2006
2	Alanine Transaminase (SGPT)IBA 01/2010 - 01/2008
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2008 - 12/2006
2	Tumor Biomarkers (Tumor Markers)IBA 08/2008 - 07/2008
2	ferric oxide (iron oxide)IBA 01/2008 - 12/2005
2	IronIBA 01/2008 - 12/2006
2	Prothrombin (Factor II)IBA 01/2007 - 02/2006
2	Serum AlbuminIBA 01/2007 - 02/2006
1	Antinuclear AntibodiesIBA 02/2024
1	ledipasvirIBA 02/2024
1	SofosbuvirIBA 02/2024
1	lenvatinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CalciumIBA 07/2015
1	Pentetic Acid (DTPA)FDA LinkGeneric 09/2012
1	JNK Mitogen-Activated Protein KinasesIBA 04/2012
1	CholesterolIBA 01/2011
1	diethylenetriamineIBA 01/2011
1	AlbuminsIBA 01/2011
1	Branched-Chain Amino AcidsIBA 01/2011
1	AcidsIBA 01/2011
1	FluorocarbonsIBA 05/2010
1	Ethanol (Ethyl Alcohol)IBA 12/2009
1	ethanolamine oleate (Ethamolin)FDA Link 12/2009
1	lentil lectinIBA 08/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2008
1	Vitamin K FDA Link 01/2007
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2007
1	HepcidinsIBA 12/2006
1	BilirubinIBA 02/2006
1	Therapeutic UsesIBA 07/2003
1	HemosiderinIBA 07/2003

Therapy/Procedure

20	Therapeutics 12/2015 - 01/2003
20	Radiofrequency Ablation 07/2010 - 01/2003
6	Microbubbles 05/2010 - 06/2003
4	Aftercare (After-Treatment) 02/2024 - 03/2003
2	Drug Therapy (Chemotherapy) 12/2015 - 07/2010
2	Surgical Instruments (Clip) 12/2004 - 01/2003
2	Intravenous Injections 09/2003 - 03/2003
1	Sclerotherapy 12/2009
1	Catheters 12/2009
1	Hepatectomy 08/2008
1	Liver Transplantation 01/2007
1	Electrodes (Electrode) 07/2004
1	Erythrocyte Transfusion 07/2003